Desensitizing drug product
Desensitizing drug products, methods of making desensitizing drug products, and methods of using desensitizing drug products including delivery of desensitizing drug products. In one embodiment, the desensitizing drug products are male genital desensitizers that comprise one or anesthetic agents and one or more melting point depressing agents.
1. A method for treating premature ejaculation in males, comprising the step of administering to a male subject a male genital desensitizer composition, wherein the male genital desensitizer composition comprises:
an anesthetic agent selected from the group consisting of lidocaine, tetracaine, procaine, mepivacaine, bupivacaine, and etidocaine; and
an alcohol selected from the group consisting of methanol, propanol, isopropyl alcohol, butanol, ethanol, menthol, and eugenol;
and wherein the male genital desensitizer composition does not comprise prilocalne.
2. A method according to claim 1 , wherein the anesthetic agent is lidocaine and the alcohol is ethanol.
3. A method according to claim 1 , wherein the male genital desensitizer composition further comprises an aqueous solution, and wherein the aqueous solution comprises a pH in the range of about 6.9 to about 8.9.
4. A method according to claim 2 , wherein the male genital desensitizer composition further comprises an aqueous solution, and wherein the aqueous solution comprises a pH in the range of about 6.9 to about 8.9.
5. A method according to claim 2 , wherein the male genital desensitizer composition further comprises an aqueous solution, and wherein the aqueous solution comprises a pH of about 6.9.
6. A method according to claim 2 , wherein the male genital desensitizer composition further comprises an aqueous solution, and wherein the aqueous solution comprises a pH of about 7.9.
7. A method according to claim 2 , wherein the male genital desensitizer composition further comprises an aqueous solution, and wherein the aqueous solution comprises a pH of about 8.9.
8. A method according to claim 1 , wherein the ratio of the anesthetic agent to thymol is 9:1 by weight.
9. A method according to claim 3 , wherein the ratio of the anesthetic agent to thymol is 9:1 by weight.
10. A method according to claim 1 , wherein the male genital desensitizer composition further comprises an aqueous solution, and wherein the aqueous solution comprises a pH of about 6.9.
11. A method according to claim 1 , wherein the male genital desensitizer composition further comprises an aqueous solution, and wherein the aqueous solution comprises a pH of about 7.9.
12. A method according to claim 1 , wherein the male genital desensitizer composition further comprises an aqueous solution, and wherein the aqueous solution comprises a pH of about 8.9.
13. A method according to claim 2 , wherein the ratio of lidocaine to thymol is about 9:1 by weight.